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ABSTRACT 
Background. Diabetes mellitus (DM) is a common condition. The high burden of 
undiagnosed DM and lack of large population studies make accurate prevalence estimations 
difficult, especially in the surgical environment. Furthermore, poorly controlled DM is 
associated with an increased risk of perioperative complications and mortality. 
Objectives. The primary objective was to establish the prevalence of DM in elective adult 
non-cardiac, non-obstetric surgical patients in Western Cape hospitals. The secondary 
objectives were to assess the glycaemic control and compliance with treatment of known 
diabetics. 
Methods. This was a five-day, multicentre, prospective observational study performed at six 
government-funded hospitals in the Western Cape. Screening for DM was done using finger- 
prick capillary blood glucose (CBG) testing. Patients found to have a CBG of ≥ 6.5 mmol/L 
had an HbA1c level done. DM was diagnosed based on the Society for Endocrinology, 
Metabolism and Diabetes of South Africa (SEMDSA) diagnostic criteria. Patients known 
with DM had an HbA1c performed and Morisky Medication Adherence Scale (MMAS-4) 
questionnaires completed, to assess glycaemic control and compliance with treatment. 
Results. Of the 379 participants, 61 were known diabetics (16.15%; 95% CI 12.4-19.8%). 
After exclusion of eight patients with incomplete results, a new diagnosis of DM was made in 
five out of 310 patients (1.6%; 95% CI 0.2-3.0%). Overall prevalence of DM was 17.8% 
(66/371; 95% CI 13.9-21.7%). HbA1c results were available in 57 (93.4%) of the 61 known 
diabetics. Of these 27 (47.4%; 95% CI 34.4-60.3%) had an HbA1c level≥8.5% and 14 
(24.6%; 95% CI 13.4 – 35.8%) had an HbA1c ≤7%. Based on positive responses to two or 
more questions on their MMAS-4 questionnaires, 12 out of 60 participants (20%) were 
deemed non-compliant. 
Conclusion. There is a low rate of undiagnosed DM in our elective surgical population; 
however there is a large proportion of poorly controlled DM. Since poorly controlled DM is 
known to increase postoperative complications, this likely increases the burden of 
perioperative care. Resources should be focused on improvement of long-term glycaemic 
control in patients presenting for elective surgery. 
Abstract word count: 332 
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ABSTRACT 
Background. Diabetes mellitus (DM) is a common condition. The high burden of 
undiagnosed DM and lack of large population studies make accurate prevalence estimations 
difficult, especially in the surgical environment. Furthermore, poorly controlled DM is 
associated with an increased risk of perioperative complications and mortality. 
Objectives. The primary objective was to establish the prevalence of DM in elective adult 
non-cardiac, non-obstetric surgical patients in Western Cape hospitals. The secondary 
objectives were to assess the glycaemic control and compliance with treatment of known 
diabetics. 
Methods. This was a five-day, multicentre, prospective observational study performed at six 
government-funded hospitals in the Western Cape. Screening for DM was done using finger- 
prick capillary blood glucose (CBG) testing. Patients found to have a CBG of ≥ 6.5 mmol/L 
had an HbA1c level done. DM was diagnosed based on the Society for Endocrinology, 
Metabolism and Diabetes of South Africa (SEMDSA) diagnostic criteria. Patients known 
with DM had an HbA1c performed and Morisky Medication Adherence Scale (MMAS-4) 
questionnaires completed, to assess glycaemic control and compliance with treatment. 
Results. Of the 379 participants, 61 were known diabetics (16.15%; 95% CI 12.4-19.8%). 
After exclusion of eight patients with incomplete results, a new diagnosis of DM was made in 
five out of 310 patients (1.6%; 95% CI 0.2-3.0%). Overall prevalence of DM was 17.8% 
(66/371; 95% CI 13.9-21.7%). HbA1c results were available in 57 (93.4%) of the 61 known 
diabetics. Of these 27 (47.4%; 95% CI 34.4-60.3%) had an HbA1c level≥8.5% and 14 
(24.6%; 95% CI 13.4 – 35.8%) had an HbA1c ≤7%. Based on positive responses to two or 
more questions on their MMAS-4 questionnaires, 12 out of 60 participants (20%) were 
deemed non-compliant. 
Conclusion. There is a low rate of undiagnosed DM in our elective surgical population; 
however there is a large proportion of poorly controlled DM. Since poorly controlled DM is 
known to increase postoperative complications, this likely increases the burden of 
perioperative care. Resources should be focused on improvement of long-term glycaemic 




Diabetes mellitus (DM) is a common condition, affecting an estimated 15.5 million people in 
Africa. Importantly, the prevalence of DM across the continent is expected to double by 2045.[1] 
Since 2015, this condition has been ranked as the second most common cause of natural death 
in South Africa, and the impact on health care provision is substantial.[2] Accurate assessment 
of prevalence is difficult due to the high burden of undiagnosed DM (estimated at 69% in 
Africa), and the lack of large population studies.[1] In South Africa, the prevalence of DM is 
estimated to be between 5.4% and 9.2%.[1,3] There is limited data reporting the prevalence of 
DM in the Western Cape, South Africa, and minimal information with regards to elective 
surgical patients. Many studies have shown that DM, especially if poorly controlled, is 
associated with an increased risk of perioperative complications and mortality.[4-9] In South 
Africa, insulin dependent surgical patients are twice as likely to die in hospital than non- 
diabetics.[10] 
The objective of this study was to establish the prevalence of DM in patients presenting for 
elective surgery over a one-week period in six Western Cape hospitals. The secondary 
objectives were to assess; i) the glycaemic  control of known diabetics presenting for surgery, 
using the HbA1c level, and ii) the compliance with treatment, by means of the Morisky 




Study approval was obtained from the University of Cape Town Faculty of Health Science 
Human Research Ethics Committee (UCT HREC: 386/2017), the Western Cape Department 
of Health, as well as institutional approval from all participating centres 
(NHRD:WC_201709_018). The study was registered on Clinicaltrials.gov (NCT03318055). 
Written informed consent was provided by all participants prior to enrolment. This study is 
presented according to the Strengthening the Reporting of Observational Studies in 
Epidemiology (STROBE) guidelines.[12] 
This was a multicentre, prospective observational study performed at six government-funded 
hospitals in the Western Cape, South Africa: Groote Schuur-, Somerset-, Paarl-, Victoria-, 
Mitchell’s Plain- and George Hospital. A pre-study power calculation based on an expected 
prevalence in the South African surgical patient population of DM of 10%[10] and an estimated 
sample size of 500 (expected number of elective surgical procedures in the participating 
hospitals) allowed for an estimate of the prevalence with a 95% confidence interval of ± 
2.65%, i.e. 7.35%-12.65%. Convenience sampling was practised, during the daytime hours 
(07:00-19:00) of a calendar week (Monday 16 October to 
    
Exclusion criteria were patient refusal or inability to consent, emergency and cardiac surgery, 
and pregnant and paediatric (<18 years old) patients. All participants were seen preoperatively 
by the anaesthesia medical staff, and after written consent was obtained, demographic and 
baseline data was collected and recorded on the case report form (CRF) (see Appendix). 
The diagnosis of DM in our study was based on recommendations of the Society for 
Endocrinology, Metabolism and Diabetes of South Africa (SEMDSA)[13], which states that the 
diagnosis can be made in ‘an asymptomatic patient when any one of the following tests, 
repeated on separate days within a two-week period are confirmed: i) fasting plasma glucose ≥ 
7.0 mmol/L, ii) 2 hour-post glucose load ≥ 11.1 mmol/L, or iii) HbA1c ≥ 6.5%. In the event that 
both a glucose-based test and the HbA1c test are measured, if both are ‘diagnostic’ for diabetes, 
then the diagnosis of diabetes is confirmed.’ 
An HbA1c level was measured in known diabetics who did not have a test result within the 
preceding 90 days. As HbA1c levels reflect glycaemic control over the preceding  
10 
 
12 weeks, if a recent result was available, the test was not repeated to save on costs.  
Screening for DM was done using finger-prick capillary blood glucose 
(CBG) testing in all consenting participants undergoing elective surgery. The mandatory 
starvation period of at least six hours for elective surgical patients was used as the fasting period 
for the fasting glucose measurement. Based on the recommended correction of CBG to reflect 
a true plasma glucose (plasma glucose (mmol/L) = 0.102 + 1.066 x CBG)[13] a capillary glucose 
level of ≥ 6.5 mmol/L was taken as a cut-off to reflect a plasma level ≥7.0 mmol/L. Patients 
found to have a CBG of ≥ 6.5 mmol/L had an HbA1c level done to confirm the diagnosis of 
diabetes. 
HbA1c results were linked via a unique CRF-generated laboratory number. Data was recorded 
on paper CRFs, and captured electronically onto the Research Electronic Data Capture 
(REDCap) application. Access to REDCap was protected by username and password. Patient 
confidentiality and anonymity were protected through unique numerical code generation 
during electronic data capturing. Patients identified as having raised fasting CBG were given 
referral letters to their primary health care facilities for further investigations and management. 
The primary objective of this study was to determine the prevalence of diabetes in the elective 
surgical population. This included patients with a previous diagnosis of DM, and a new 
diagnosis based on the screening CBG and confirmatory elevated HbA1c level. The secondary 
objectives of this study were to assess: i) the glycaemic control and, ii) the compliance with 
treatment of participants already known with DM. Glycaemic control was determined by the 
HbA1c levels. SEMDSA advocates aiming for an HbA1c of ≤7% in most patients (well 
controlled DM). An HbA1c level of 7.1 to 8.5% is considered moderate control and may be 
acceptable in the following patient categories: elderly, frail, limited life expectancy, multiple 
co-morbidities, severe vascular disease, advanced chronic kidney disease, recurrent severe 
hypoglycaemia, or unawareness of hypoglycaemia.[13] An HbA1c  of ≥8.5% is considered poor 
control. Compliance with treatment was assessed using the MMAS-4 score.[11] Non- 





Continuous variables with normal distribution were described as mean and standard deviation 
(SD). Between-group comparisons were performed using Fisher’s exact test, except for age (t- 
test) and in contingency tables which were more than 2 by 2 comparisons (ASA classification 
and functional status) where the Pearson’s Chi-Square test was used. The Statistical Package 






The study flow diagram is shown in Figure 1. The breakdown of contribution to final 
participant numbers from each hospital is displayed in Table 1. Participants known to have DM 
comprised 16.1% (61/379; 95% CI 12.4-19.8) of the study population. Of the 318 participants 
who were not previously diagnosed with DM, 310 (97.5%) had CBG and, where appropriate, 
HbA1c results available. A new diagnosis of DM was made in an additional 1.6% (5/310; 95% 
CI 0.2-3.0) of participants not previously known with DM. Therefore, the overall prevalence 
of DM was 17.8% (66/371; 95% CI 13.9-21.7). Of the 66 diabetic participants, 7.5% (5/66; 
95% CI 1.2-13.9) were diagnosed during the study. 
The demographic details of the study population are shown in Table 2. Univariate analysis 
showed an association between DM and increasing age, increasing American Society of 
Anesthesiologists’ Physical Status (ASA) classification, decreasing functional status, and co- 
morbidities. Based upon positive responses to two or more questions on the MMAS-4 





In our study population, one in six participants presenting for surgery was diabetic. Of the 
participants with DM, 92.5% were known diabetics prior to surgery, but almost one in two had 
poor glycaemic control as reflected by an HBA1c level ≥8.5%. 
Strengths of the study 
The strength of this investigation was that it was a multicentre, prospective study that involved 
several regions in the Western Cape, South Africa. The research provided the most 
comprehensive data to date of the prevalence of diabetes in this elective adult surgical patient 
population, and therefore has implications for determining appropriate management plans for 
this population. In comparison with some previous prevalence studies, this study did not rely 
solely on self-reporting of DM or single CBG results; therefore we believe it is a more accurate 
representation of the true prevalence of diabetes and the degree of glycaemic control in these 
elective surgical patients. 
Relation to other studies 
The prevalence of DM in our study was higher than reported in non-surgical South African 
population studies. The International Diabetes Federation country level DM estimates (5.4% 
for South Africa) were based on the weighted average of the scores of all data sources in the 
adult population.[1] The South African National Health and Nutrition Examination Survey 
(SANHANES) utilised a multi-stage disproportionate, stratified cluster sampling approach to 
the general population based on census data, and demonstrated a 9.2% prevalence of DM (self- 
reported, and HbA1c ≥6.5%) in the adult population.[3] The prevalence of DM increases with 
age, and the higher mean age of our study population than that of the general South African 
population likely contributes to the higher prevalence of DM reported.[14] 
Studies of surgical patients report a higher prevalence of DM than in the population overall. 
The South African Surgical Outcomes Study (SASOS) reported a South African national 
prevalence of self-reported DM of 10.1%.[10]  This is considerably lower than we have shown. 
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When investigating elective surgical patients in the Western Cape, van der Spuy et al. showed 
a prevalence of 16% of self-reported DM, which is in keeping with our findings.[15] However, 
neither of these studies evaluated the prevalence of undiagnosed DM at the time of surgery, 
nor the degree of glycaemic control. 
Using CBG and HbA1c level as screening and diagnostic tools, our study identified a low 
prevalence of undiagnosed DM of 1.6% (5/310) in this surgical population. This is a 
considerably lower value than reported in a general population study by Bailey et al, which 
estimated an undiagnosed prevalence of DM, (based on random CBG measurement) in the 
Western Cape, of 12.7%.[16]  In 2012 Erasmus et al found a prevalence of undiagnosed DM 
(based on oral glucose tolerance tests and HbA1c) of 18.2% in adults in a community in 
Bellville, Western Cape.[17] The reasons for the lower prevalence in our study likely include: i) 
the stringent diagnostic criteria applied in our study, and ii) the fact that all participants in our 
study had been assessed preoperatively by multiple health care practitioners. 
Clinical implications 
Our data suggest that DM screening for patients accessing elective surgery (often via primary 
health care) is well-established in the studied health care services. Based on our findings, we 
suggest that screening for DM is not a priority in the preoperative period. This is in keeping 
with conclusions from a systematic review that routine blood glucose or HbA1c levels are not 
needed in otherwise well non-diabetic patients presenting for general (non-orthopaedic or 
vascular) surgery.[18] Cognisance must be taken of the fact that a small number of patients 
present with undiagnosed DM. The prevalence of DM and access to primary health care and 
hospitals are extremely variable within South Africa, and care must be taken in generalising 
these findings over too broad a population base. 
Multiple studies have shown that poor glycaemic control in the preoperative period is 
associated with increased complication rates in the perioperative period. These include 
increased length of stay,[4] higher risk of failure of total ankle replacements,[5] increased 
infection rates in hip and knee arthroplasty,[6]  and raised risk of poor postoperative glycaemic 
control and postoperative complications.[7]. In 2015 Kallio et al demonstrated that referral of 
poorly controlled diabetic patients (HbA1c >10%) to primary health care services for 
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optimisation of glycaemic control before proceeding with total joint arthroplasty resulted in 
lower complication rates and shorter hospital stays.[19] 
The United Kingdom National Health Service (NHS) Consensus Guidelines of 2011,[20] 
endorsed by the Association of Anaesthetists of Great Britain and Ireland Working Party,[21] 
recommend postponing elective surgery in patients with an HbA1c level ≥8.5%, to allow for 
improved glycaemic control. In our study, 47% of diabetic participants had an HbA1c exceeding 
this level. If these guidelines were to be adopted in the Western Cape, it is likely that a 
significant proportion of diabetic patients would have their surgery postponed. 
In our resource-limited environment patients may experience long delays accessing elective 
surgery. Last minute postponement of surgery to allow for improved glycaemic control may 
not be practical. If poor control is timeously identified, the long waiting period presents an 
opportunity for optimisation of treatment without increasing the delay before surgery. Limited 
access to good quality diabetes care is a major concern: an analysis of data from the 
SANHANES study estimated that only 19.4% of patients with DM in South Africa are both 
identified and well controlled,[22] which is in keeping with our findings, where only 24.6% of 
patients known with DM had good control (HbA1c level ≤ 7%). 
As a secondary outcome, compliance was assessed, using the MMAS-4 questionnaire. Only 
one of every five participants was noted to be non-compliant, which is similar to the prevalence 
of self-reported non-compliance to DM medication of 30% in the Limpopo province.[23] In our 
study, no conclusions could be drawn with respect to correlation between compliance and 
glycaemic control. Verbal questionnaires to establish compliance have limited reliability. We 
employed the MMAS-4 questionnaire since this tool has been described as the nearest to the 
gold standard.[24] Despite the reported compliance rate of 80% in our study population, 47.4% 
of the diabetic participants were found to be poorly controlled, with an HbA1c level of ≥8.5%. 
Interpreting the reasons for the disparity between reported medication compliance and 
glycaemic control is complex. Factors contributing to glycaemic control may include the 
prescribing and availability of correct medication, as well as lifestyle factors, such as exercise 
and diet. 
Limitations of the study 
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This study has some limitations. Smaller patient numbers were recruited than expected (379 
versus 500) due to the withdrawal of one of the hospitals initially planned to be an active site. 
This minimally increased the 95% CI associated with the estimation of the prevalence of 
diabetes in this population from 5,3 to 8%. 
Nil per os guidelines followed in the participating hospitals were a minimum of six hours for 
solid food, and two hours for clear fluids. In practice, most patients had longer nil per os times 
than this minimum requirement. SEMDSA guidelines state that ‘fasting is defined as no caloric 
intake for at least eight hours’.[13] It is possible that participants may have had oral or 
intravenous glucose containing fluids within eight hours preoperatively, which might have 
affected the CBG result. Fasting status would not affect HbA1c level results. Since HbA1c was 
used as a defining result for DM, we are confident that we did not overestimate the prevalence 
of DM in our study population. 
The SEMDSA guidelines advise that bedside tests (glucose and HbA1c level) should not be 
used to diagnose DM unless laboratory-based tests are unavailable.[13]  For reasons of  clinical 
convenience,  and  to  make  our  study  practicable,  we  used  finger-prick  CBG  levels. We 
conducted laboratory HbA1c testing as a defining result to diagnose DM. The SEMDSA 
guidelines also state that ‘if only one of these tests is abnormal, a second abnormal result of the 
same testing method is required to confirm the diagnosis of diabetes on a different day, 
preferably within two weeks’.[13]  Fourteen of our participants had a raised CBG level, with an 
HbA1c level <6,5%, and were not followed up. Our results may therefore underestimate the 
prevalence of undiagnosed diabetes in this surgical population. 
Suggested further research 
This study provides an objective assessment of the prevalence and glycaemic control of DM in 
the perioperative patient population in the Western Cape, South Africa. The poor control of 
DM in the perioperative period suggests that further research is needed to evaluate the 
perioperative complication rates in these patients. Interventions to improve long term 





DM is a common disease that is associated with increased perioperative complications. It is 
well diagnosed, but poorly managed in our study population. We recommend that early 
identification of poorly managed DM (by HbA1c measurement) should be prioritised in elective 
surgical patients. This could result in timeous referral to the appropriate services for 
improvement of glycaemic control before surgery, and in turn allow time for improvement of 
preoperative management of DM, without causing a significant increase in surgical waiting 
times. Overall, the goal would be lower perioperative complication rates. 
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TABLES AND FIGURES 
Table 1: Participating hospitals 
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Hospitals Number of participants (n= 379) 
Groote Schuur 176 
George 58 
Paarl 42 
New Somerset 40 
Victoria 35 













No HbA1c result 
4 








CBG ≥6.5 mmol/L 
21 
CBG < 6.5 mmol/L 
291 






Figure 1: Study flow diagram 
CBG: capillary blood glucose 
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Table 2: Characteristics of the study population. 
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ASA American Society of Anaesthesiologist’s physical status 
transient ischaemic attack 
classification system; TIA 
Denominators vary as patients with missing data excluded. 
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Table 3: Glycaemic control of known diabetics based on HbA1c results n (%; 95% CI) 
27 
HbA1c ≤7 HbA1c 7.1-8.4 HbA1c ≥8.5 
 
 
Known diabetics 14 (24.6; 13.4 – 35.8) 16 (28.1; 16.4-39.7) 27 (47.4; 34.4-60.3) 
 
APPENDIX 1 
Consent given □ Yes 
EPIC I - Study 
□ No 
Gender  □  M □ F Current  smoker □ Y □ N Age years 
Ethnicity: □ Black □ Coloured 
Weight 
□ Asian □Caucasian 
Height cm 
kg ASA  □  I □  II □  III □ 
□ V IV 
Most recent formal blood results (no more than 3 months before surgery): No recent formal bloods □ 
Haemoglobin g/dL HbA1c % s - Ferritin μg/L . 
. 
. . 












□ Advanced retinopathy 
□ Known HIV / AIDS 
□ Current TB 
□ Previous PTB 
Coronary artery disease 
Stroke or Transient ischaemic attack 
Known hypertension 
Diabetes (without insulin) 
Heart failure 
COPD / Asthma 
Chronic renal disease 
□ Peripheral arterial disease 
□ Diabetes (requiring insulin) 
Functional status: 
□ Totally independent □ Partially dependent □ Totally dependent 










□ ENT (except thyroid/parathryroid) 





Intestinal □ Neck (thyroid/parathyroid) □ Gynaecology 
□ Peripheral vascular 
□ Non-oesophageal thoracic 
□ Eye surgery 





Current medications taking for at least 30 days prior to hospital admission (tick all that apply): 




□ Folate □ Other 
EPIC I unique patient ID 
 
Patient name:   DOB 
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y y y y d d m m 











      
Preoperative data capture 
 
     
 
 
   
  




Drug compliance (tick all that apply)? : 
1) Do you ever forget to take your medication? □ Y □ N 
2) Are you careless at times about taking your medication? □ Y □ N 
3) When you feel better, do you sometimes stop taking your medication? □ Y □ N 
4) Sometimes if you feel worse when you take the medicine, do you stop taking it? □ Y □ N 
This questionnaire applies to: □ Both diabetic and anaemia therapy □ Anaemia only □ Diabetic therapy 
only Reasons for non-drug compliance (only answer if 2 or more drug compliance questions above marked 
‘Yes’): Health system □ Condition □ Patient □ Therapy □ Socioeconomic □ 
Surgery performed: □Yes □No: 
If No, state reason for cancellation □ Poor diabetic control □ Low haemoglobin □ Other reason 
Blood/products ordered for theatre: □ Group & Screen only □ Blood Cross-matched □ Blood in theatre 
Major surgery: □ Y □ N 
Expected blood loss > 500ml: □ Y □ N 
Ward results (only if done preoperatively in ward) 
Pre-induction Finger prick blood results 
Post operative Follow-up of Formal Blood Results (to be completed by EPIC Investigators 
□     
Patient name:   DOB 
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y y y y d d m m 
Haemoglobin   g/dL Transferrin saturation . 
  
. 
 % s - Ferritin   . 
 μg/L 
 
MCV % HbA1c % 
. . 
EPIC I unique patient ID            
  
Haemoglobin   . 
 g/dL Glucose   . 
 mmol/L 
If Haemoglobin ≤ 13 g/dL (M) or ≤ 12 g/dL (F) - □ Purple and Yellow top blood samples taken 
If Glucose ≥ 6.5 g/dl - □ Purple top blood samples taken 
 
NB ! Document the PID number here 
Note: if bloods taken for both anaemia and diabetes, there need to be two separate ‘Purple top’ tubes please 
 
      
Haemoglobin   . g/dL Glucose 
  
. mmol/L 
Blood transfusion prior to surgery (on this admission): □ Y □ N 
If known diabetic, was the patient on a perioperative sliding scale □ Y □ N 
Perioperative data capture 
 
   
      
 
  




Guidance for use of paper Case Record Form (CRF) 
1. Baseline data on page one and consent should be collected on the preoperative anaesthetic 
visit the day before surgery. 
Baseline data on page two should be collected by the anaesthetist who provides the 
anaesthetic for the patient. 
Ward blood results are referring to the routine ward Hb and glucose performed by the ward 
staff and documented on the preoperative checklist form. 
“Finger-prick” blood and samples to be taken pre-induction at time of intravascular access. 
Additional blood sample for formal blood results should be collected if: 
a. Haemoglobin ≤ 13 g/dl (M) or ≤ 12 g/dl (F) for formal HB, MCV (purple top 
tube) and transferrin saturation and ferritin (yellow top tube) 






i) Remember to copy the Patient ID nr (PID) on the blood sample tubes and 
ii) Bloods taken for both anaemia and diabetes, there need to be two 
separate ‘purple top’ tubes 
iii) Follow-up of these formal bloods (bottom of page 2) will be done by the 
EPIC investigators 
5. Definitions: 
a. Major surgery: defined as Aortic and other major vascular surgery, peripheral 
vascular surgery, or intraperitoneal or intrathoracic surgery with major fluid shifts 
b. Non-drug compliance definitions;2 
i. Health system: Poor quality of provider-patient relationship; poor 
communication; lack of access to healthcare; lack of continuity of care 
Condition: Asymptomatic chronic disease (lack of physical cues); mental 
health disorders (eg, depression) 
Patient: Physical impairments (eg, vision problems or impaired dexterity); 
cognitive impairment; psychological/behavioural; younger age) 
Therapy: Complexity of regimen; side effects 





6. Please ensure complete data capture. If blood results are not available at the time of 
the preoperative anaesthetic assessment, please can the anaesthetist for the operative 




INFORMED CONSENT FORM 
EPIC 1 - Evaluating Perioperative Interventions to improve patient outComes 1 
Title of Studies: 
Study 1: An audit of the prevalence of anaemia in patients presenting for elective surgery 
in selected hospitals in the Western Cape 
Study 2: An audit of the prevalence of abnormal fasting blood glucose levels in patients 
presenting for elective surgery at a selection of Western Cape government hospitals. 
Investigators: Dr Willem Conradie, Dr Tessa Biesman-Simons, Dr Marcin Nejthardt, Dr Francois 
Roodt, Prof Bruce Biccard, Prof Robert Dyer, Dr Margot Flint 
Department of Anaesthesia and Perioperative Medicine, University of Cape Town, South Africa 
INFORMATION 
The doctors in this study are trying to find out how common diabetes and anaemia are in patients 
coming for surgery. 
Diabetes is a condition whereby the blood sugar is too high. If left untreated it increases the risk 
of heart attack, stroke, kidney failure and blindness. Anaemia is when the blood is ‘too thin’ 
which can lead to feeling fatigued and increase the chance of needing a blood transfusion during 
surgery. Anaemia can also increase complications after surgery. There are many causes of 
anaemia but one of the common reasons is a low iron level in the blood. 
By understanding how common the two conditions are will allow doctors and to set up programs 
to manage these treatable conditions more effectively. 
Taking part is purely voluntary and by not agreeing to take part will not affect your normal care 
for surgery. The results of the tests may however be of great benefit to you. 
What will happen? 
A blood test is needed to test for diabetes and anaemia. In diabetes, the blood sugar level is high 
whilst in anaemia haemoglobin is low. Haemoglobin is a normal substance made up of iron that 
carries oxygen in the blood. This is the reason why iron is measured to check if the blood is too 
thin. 
As part of normal preparation for surgery blood tests are taken to test haemoglobin concentration. 
This blood test may be done as either as a finger prick to get a drop of blood or a small tube of 
blood may be needed to test other things that your doctor thinks is necessary. 
The only additional inconvenience to you is a finger prick to test for blood sugar just before 




need to take a blood sample to confirm that the result is accurate and also get an impression of 
how high your sugar has been in the last 3 months. This would be done at the same time as the 
drip so no additional needle sticks should be necessary. The testing of low iron would be done 
at the same time. 
As part of normal care, doctors discuss any medical problems that you may have. This 
information is used to plan appropriately for your procedure. In the study, the doctor would do 
exactly the same but ask you a few additional questions about the medication that you’re taking. 
The details of the discussion would be recorded on a page which would have no personal 
identifiers, in other words the information would be anonymous and could not be traced back to 
you. 
Is there any benefit to me? 
Yes. 
By knowing if you are diabetic or at risk of diabetes can lead to appropriate life style changes 
and treatment, both of which have proven effect to minimise complications such as heart atttacks, 
strokes, kidney failure and blindness. By knowing that you have thin blood and finding out that 
the cause is low iron can lead to effective treatment to improve fatigue and improve circulation. 
You would also be given a referral letter to your local day hospital/healthcare provider informing 
them of your abnormal sugar or anaemia which will enable appropriate follow up. 
Is there any potential harm to me? 
A finger prick carries an extremely low risk of infection. Also, the additional blood that may be 
taken if your blood is thin or you have a high sugar is very small amount (less than a tablespoon) 
which will have no effect on your body. We believe that the benefits far outweigh any risk. 
The information from this study will be used to publish in a medical journal and presented at 
professional meetings in order to improve patient care. 
The investigators have received permission for this research from the Human Research Ethics 
Committee (HREC no: 386/1017). If you have any concerns or questions regarding the study 
you can contact the researchers directly on 021 404 5001. If you have any ethical concerns you 
can contact the Human Ethics Research Committee on 021 406 6338. 
Please read this form carefully and ask the investigator (study doctor) to explain any words or 
information that are not clear to you. This will help to ensure you understand the details of your 
participation before you give your consent. You will be given a copy of this consent form to take 
home with you. The doctors will answer any questions you may have about this consent form 
and about the studies 
CONSENT STATEMENT 
I therefore certify the following: 
• I have read the above information form and understand that the study involves research. 
I understand that the doctors will make a copy of some of my routinely recorded data • 
from my standard patient care. 
32 
 
• I have had the opportunity to ask questions. All my questions have been answered to my 
satisfaction. 
• I understand that any information that leaves the doctor’s office will be de-identified (i.e., 
identifying information will be removed from the documents). 
  YES   NO 
Participant/Legal Representative’s name (printed) Signature Date: 





To: Primary Health Care Facility 
Re: 
Please note that the above patient participated in the Evaluation of Perioperative 
Interventions (EPIC 1) study to screen for diabetes mellitus and anaemia in patients 
presenting for elective surgery. 
It was found that the patient had the following abnormal blood result/s 
Normal values: 
Fasting Glucose: Normal 2.9-6.0mml/l 
Impaired 6.1-6.9 mmol/l 
Diabetic ≥7.0 mmol/l 
Haemoglobin: Males >13g/dl 
Females > 12g/dl 
Implication of the results: 
 The elevated finger prick glucose and HbA1c reflect a poor glucose control. The 
patient will require appropriate long term follow up and management of possible 
diabetes mellitus. 
 The low haemoglobin defines an anaemia and the most likely cause in a 
postoperative patient would be iron deficiency. The patient will require oral iron 
supplementation and subsequent rechecking of their haemoglobin. 
 The patient was given information about the implication of the abnormal result and 
is being referred to you as the primary care facility that will take over ongoing 
review and appropriate treatment. 
If you have any queries related to the study or the implication of the result you can contact 
the investigators on the following number: 
Telephone: 021 404 5001 
With best intentions 
The EPIC Investigators 
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Fasting finger prick glucose …………  mmol/l Pre-operative haemoglobin ................. g/dl 
 HbA1c .............. % 







Signature removed to avoid exposure online
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will enable identification. 
Please remove title page, acknowledgements, contact details, funding grants to a named person, and any 
running headers of author names. 
Mask self-citations by referring to your own work in third person. 
General article format/layout 
Accepted manuscripts that are not in the correct format specified in these guidelines will be returned to 
the author(s) for correction, which will delay publication. 
General: 
Manuscripts must be written in UK English. 
The manuscript must be in Microsoft Word format. Text must be single-spaced, in 12-point Times New 
Roman font, and contain no unnecessary formatting (such as text in boxes). 
Please make your article concise, even if it is below the word limit. 
Qualifications, full affiliation (department, school/faculty, institution, city, country) and contact details 
of ALL authors must be provided in the manuscript and in the online submission process. 
Abbreviations should be spelt out when first used and thereafter used consistently, e.g. 'intravenous 
(IV)' or 'Department of Health (DoH)'. 
Include sections on Acknowledgements, Conflict of Interest, Author Contributions and Funding 
sources. If none is applicable, please state ‘none’. 
Scientific measurements must be expressed in SI units except: blood pressure (mmHg) and haemoglobin 
(g/dL). 
Litres is denoted with an uppercase L e.g. 'mL' for millilitres). 
Units should be preceded by a space (except for % and ºC), e.g. '40 kg' and '20 cm' but '50%' and '19ºC'. 
Please be sure to insert proper symbols e.g. µ not u for micro, a not a for alpha, b not B for beta, etc. 
Numbers should be written as grouped per thousand-units, i.e. 4 000, 22 160. 
Quotes should be placed in single quotation marks: i.e. The respondent stated: '...' 
Round brackets (parentheses) should be used, as opposed to square brackets, which are reserved for 
denoting concentrations or insertions in direct quotes. 
If you wish material to be in a box, simply indicate this in the text. You may use the table format –this is 
the only exception. Please DO NOT use fill, format lines and so on. 
SAMJ is a generalist medical journal, therefore for articles covering genetics, it is the responsibility of 
authors to apply the following: 
- Please ensure that all genes are in italics, and proteins/enzymes/hormones are not. 
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- Ensure that all genes are presented in the correct case e.g. TP53 not Tp53. 
**NB: Copyeditors cannot be expected to pick up and correct errors wrt the above, although they will 
raise queries where concerned. 
- Define all genes, proteins and related shorthand terms at first mention, e.g. ‘188del11’ can be glossed 
as ‘an 11 bp deletion at nucleotide 188.’ 
- Use the latest approved gene or protein symbol as appropriate: 
Human Gene Mapping Workshop (HGMW): genetic notations and symbols 
HUGO Gene Nomenclature Committee: approved gene symbols and nomenclature 
OMIM: Online Mendelian Inheritance in Man (MIM) nomenclature and instructions 
Bennet et al. Standardized human pedigree nomenclature: Update and assessment of the 
recommendations of the National Society of Genetic Counselors. J Genet Counsel 2008;17:424-433: 
standard human pedigree nomenclature. 
Research 
Guideline word limit: 4 000 words 
Research articles describe the background, methods, results and conclusions of an original research 
study. The article should contain the following sections: introduction, methods, results, discussion and 
conclusion, and should include a structured abstract (see below). The introduction should be concise – 
no more than three paragraphs – on the background to the research question, and must include 
references to other relevant published studies that clearly lay out the rationale for conducting the study. 
Some common reasons for conducting a study are: to fill a gap in the literature, a logical extension of 
previous work, or to answer an important clinical question. If other papers related to the same study 
have been published previously, please make sure to refer to them specifically. Describe the study 
methods in as much detail as possible so that others would be able to replicate the study should they 
need to. Results should describe the study sample as well as the findings from the study itself, but all 
interpretation of findings must be kept in the discussion section, which should consider primary 
outcomes first before any secondary or tertiary findings or post-hoc analyses. The conclusion should 
briefly summarise the main message of the paper and provide recommendations for further study. 
Select figures and tables for your paper carefully and sparingly. Use only those figures that provided 
added value to the paper, over and above what is written in the text. 
Do not replicate data in tables and in text. 
Structured abstract 
This should be 250-400 words, with the following recommended headings: 
Background: why the study is being done and how it relates to other published work. 
Objectives: what the study intends to find out 
Methods: must include study design, number of participants, description of the intervention, primary 
and secondary outcomes, any specific analyses that were done on the data. 
Results: first sentence must be brief population and sample description; outline the results according to 
the methods described. Primary outcomes must be described first, even if they are not the most 
significant findings of the study. 
Conclusion: must be supported by the data, include recommendations for further study/actions. 
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Please ensure that the structured abstract is complete, accurate and clear and has been approved by all 
authors. 
Do not include any references in the abstracts. 
Main article 
All articles are to include the following main sections: Introduction/Background, Methods, Results, 
Discussion, Conclusions. 
The following are additional heading or section options that may appear within these: 
Objectives (within Introduction/Background): a clear statement of the main aim of the study and the 
major hypothesis tested or research question posed 
Design (within Methods): including factors such as prospective, randomisation, blinding, placebo 
control, case control, crossover, criterion standards for diagnostic tests, etc. 
Setting (within Methods): level of care, e.g. primary, secondary, number of participating centres. 
Participants (instead of patients or subjects; within Methods): numbers entering and completing the 
study, sex, age and any other biological, behavioural, social or cultural factors (e.g. smoking status, 
socioeconomic group, educational attainment, co-existing disease indicators, etc)that may have an 
impact on the study results. Clearly define how participants were enrolled, and describe selection and 
exclusion criteria. 
Interventions (within Methods): what, how, when and for how long. Typically for randomised 
controlled trials, crossover trials, and before and after studies. 
Main outcome measures (within Methods): those as planned in the protocol, and those ultimately 
measured. Explain differences, if any 
Results. 
Start with description of the population and sample. Include key characteristics of comparison groups. 
Main results with (for quantitative studies) 95% confidence intervals and, where appropriate, the exact 
level of statistical significance and the number need to treat/harm. Whenever possible, state absolute 
rather than relative risks. 
Do not replicate data in tables and in text. 
If presenting mean and standard deviations, specify this clearly. Our house style is to present this as 
follows: 
E.g.: The mean (SD) birth weight was 2 500 (1 210) g. Do not use the ± symbol for mean (SD). 
Leave interpretation to the Discussion section. The Results section should just report the findings as per 
the Methods section. 
Discussion 
Please ensure that the discussion is concise and follows this overall structure – sub-headings are not 
needed: 
Statement of principal findings 
Strengths and weaknesses of the study 
Contribution to the body of knowledge 
Strengths and weaknesses in relation to other studies 
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The meaning of the study – e.g. what this study means to clinicians and policymakers 
Unanswered questions and recommendations for future research 
Conclusions 
This may be the only section readers look at, therefore write it carefully. Include primary conclusions 





Review: A multicentre prospective observational study of the prevalence and glycaemic control of 
diabetes mellitus in adult non-cardiac elective surgical patients in Western Cape hospitals 
(manuscript draft SAMJ013898) 
1. This article attempts to establish the prevalence of diabetes mellitus in adult patient for 
elective, non-cardiac and non-obstetric surgery in the Western Cape; with secondary objectives 
to assess the degree of glycaemic control and treatment compliance of known diabetics. This 
study is certainly appropriate for this journal – diabetes is an epidemic according to the WHO 
and is one of the medical conditions responsible for an enormous burden of disease 
internationally; and the complications of which are particularly onerous to treat in a resource- 
constrained country like South Africa and its African counterparts. 
This study is also original research albeit in familiar and relevant territory, and has produced 
some interesting findings with smallish numbers. It would be very interesting to see it used as 
a pilot for a national study, or to see the findings investigated further e.g. evaluating the 
efficacy of interventions (particularly in the waiting period between booking an elective 
surgical case and it actually being performed) to try to increase treatment compliance in an 
effort to reduce the incidence of perioperative complications. 
2. The article is well-written, concise and focussed. As a whole, spelling and grammar errors 
are minimal although any article worth publishing requires a thorough line-by-line beta by 
the editor. 
3. Introduction: It is concise and to-the-point, as is suited to its nature. 
4. Methods: It is gratifying to note that informed consent was obtained from the patients and 
ethics approval obtained. The description of the study is detailed but well laid out, logical and 
easy to read. The study itself follows simple and elegant lines, taking nothing away from the 
enormous amount of work it must have taken to complete. The methods described are quite 
straightforward. 
5. Results: Regarding Table 2 – as convention, and to improve readability, numbers are right- 
justified and words are left-justified. 
Under statistical analysis, Lines 57-59 look as though they may be have been minimally 
changed from the original protocol (as a guess) and more information and detail is needed 
here. They need to justify or explain when and why Pearson’s and Fisher’s were used. This 
same level of detail should be represented in Table 2 where the statistical tests used should 
be added, as well as in the p-value calculation column. 
6. Discussion: As a general comment, the discussion is appropriate; and is essentially a revision 
and extension of the work presented in the introduction, and a summary of the important and 
significant findings of the study. The author(s) does well to include the limitations of the study 
and to suggest areas of further research. 
It is also gratifying to note that cognisance is taken of the fact that although the incidence of 




the rest of South Africa due to the very variable quality of primary health care provision 
nationally. 
7. References: standard format; only 7 of 24 references are more than five years old. 
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